HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Limbic encephalitis and small cell lung cancer. Clinical and immunological features.

Abstract
Paraneoplastic limbic encephalitis (LE) is considered a particular manifestation of paraneoplastic encephalomyelitis (PEM), a remote effect of cancer almost always associated with anti-neuronal antibodies (anti-Hu; also called ANNA 1) and small cell lung carcinoma (SCLC). In order to define the frequency of anti-Hu antibodies in LE with SCLC and to analyse possible clinical differences between patients with and without anti-Hu antibodies, the charts of 16 patients with LE and SCLC were reviewed. Eight patients (50%) had anti-Hu antibodies (anti-Hu+) whereas eight patients (50%) had no detectable anti-neuronal antibodies (anti-Hu-). The clinical and laboratory features of LE and time to diagnosis of SCLC were similar in the anti-Hu+ and anti-Hu- groups. Involvement of other areas of the nervous system compatible with the diagnosis of PEM was observed in seven (87.5%) patients of the anti-Hu+ group but in only one (12.5%) of the anti-Hu- group (P = 0.012). Five patients, including four of the anti-Hu- group, had a partial improvement of the LE after treatment of the SCLC. Another anti-Hu- patient improved spontaneously. Six patients of the anti-Hu+ group died from the neurological disorder, whereas in the anti-Hu- group the cause of death was progression of the SCLC in the three patients who died. The results of this study indicate that the absence of anti-Hu antibodies does not rule out the presence of an underlying SCLC in patients with a clinical diagnosis of LE. Patients with LE and SCLC who are without anti-Hu antibodies are less likely to develop PEM and seem to improve more often after treatment of the cancer than those who present anti-Hu antibodies.
AuthorsS Alamowitch, F Graus, M Uchuya, R Reñé, E Bescansa, J Y Delattre
JournalBrain : a journal of neurology (Brain) Vol. 120 ( Pt 6) Pg. 923-8 (Jun 1997) ISSN: 0006-8950 [Print] England
PMID9217677 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antibodies, Anti-Idiotypic
  • Autoantibodies
  • ELAV Proteins
  • Nerve Tissue Proteins
  • RNA-Binding Proteins
Topics
  • Antibodies, Anti-Idiotypic (blood, immunology)
  • Autoantibodies (blood, immunology)
  • Carcinoma, Small Cell (complications, immunology, mortality)
  • Cerebrospinal Fluid (cytology)
  • ELAV Proteins
  • Encephalitis (diagnosis, etiology, immunology)
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoblotting
  • Immunosuppression Therapy
  • Limbic System
  • Lung Neoplasms (complications, immunology, mortality)
  • Lymphocytes (immunology)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Nerve Tissue Proteins
  • Paraneoplastic Syndromes (diagnosis, etiology, immunology)
  • RNA-Binding Proteins (blood, immunology)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: